1. Home
  2. GSIW vs CYCN Comparison

GSIW vs CYCN Comparison

Compare GSIW & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIW
  • CYCN
  • Stock Information
  • Founded
  • GSIW 2016
  • CYCN 2018
  • Country
  • GSIW Hong Kong
  • CYCN United States
  • Employees
  • GSIW N/A
  • CYCN N/A
  • Industry
  • GSIW
  • CYCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSIW
  • CYCN Health Care
  • Exchange
  • GSIW Nasdaq
  • CYCN Nasdaq
  • Market Cap
  • GSIW 12.3M
  • CYCN 8.4M
  • IPO Year
  • GSIW 2023
  • CYCN N/A
  • Fundamental
  • Price
  • GSIW $0.50
  • CYCN $2.88
  • Analyst Decision
  • GSIW
  • CYCN
  • Analyst Count
  • GSIW 0
  • CYCN 0
  • Target Price
  • GSIW N/A
  • CYCN N/A
  • AVG Volume (30 Days)
  • GSIW 11.8M
  • CYCN 5.8M
  • Earning Date
  • GSIW 12-31-2024
  • CYCN 03-04-2025
  • Dividend Yield
  • GSIW N/A
  • CYCN N/A
  • EPS Growth
  • GSIW N/A
  • CYCN N/A
  • EPS
  • GSIW N/A
  • CYCN N/A
  • Revenue
  • GSIW $1,313,795.00
  • CYCN $194,000.00
  • Revenue This Year
  • GSIW N/A
  • CYCN N/A
  • Revenue Next Year
  • GSIW N/A
  • CYCN N/A
  • P/E Ratio
  • GSIW N/A
  • CYCN N/A
  • Revenue Growth
  • GSIW N/A
  • CYCN N/A
  • 52 Week Low
  • GSIW $0.43
  • CYCN $1.27
  • 52 Week High
  • GSIW $13.98
  • CYCN $9.47
  • Technical
  • Relative Strength Index (RSI)
  • GSIW 46.24
  • CYCN 44.13
  • Support Level
  • GSIW $0.46
  • CYCN $2.89
  • Resistance Level
  • GSIW $0.55
  • CYCN $4.80
  • Average True Range (ATR)
  • GSIW 0.12
  • CYCN 0.75
  • MACD
  • GSIW -0.00
  • CYCN -0.11
  • Stochastic Oscillator
  • GSIW 8.33
  • CYCN 14.68

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: